医药板块速评（2023.11.17)_老虎社区_美港股上老虎 - 老虎社区

1
1
收藏

医药板块速评（2023.11.17)

牛唐
2023-11-20

1、生物医药板块接连突破，哪些优质医药股还有配置机会？ $SPDR S&P Biotech ETF(XBI)$

2、减肥药大年，还有哪些GLP-1药企有机会？ $礼来(LLY)$ $诺和诺德(NVO)$

3、 $ImmunoGen(IMGN)$ 大单看涨期权，是否有被收购机会？

$再鼎医药(ZLAB)$

# 药明合联涨超30%，港股IPO“新宠”继续持有？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

1

举报

评论（1）

推荐
最新

牛唐
·2023-12-01
$ImmunoGen(IMGN)$ 提前布局。
回复
点赞
举报

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":243588194050112,"tweetId":"243588194050112","gmtCreate":1700489577857,"gmtModify":1700489579695,"author":{"id":3452938437060827,"idStr":"3452938437060827","authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":6494,"starInvestorFlag":false},"themes":[{"themeId":"5bba0d04dd2e483aa6d779e7d44fac92","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"药明合联涨超30%，港股IPO“新宠”继续持有？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":5bba0d04dd2e483aa6d779e7d44fac92}&rnconfig={\"headerBarHidden\": true}","description":"今日药明合联首挂上市，公告显示公司发行1.78亿股股份，每股定价20.6港元，截至11月17日10: 55，盘中涨超36%，总市值达331亿港元。身处XDC热门赛道，药明合联昨日暗盘最高超涨20%，今日上市开盘继续超涨30%！药明合联的上市可以给港股打新市场助力吗？你会选择继续持有吗？","image":"https://static.tigerbbs.com/32905b448305f5d4040d4fd247484c7b"}],"images":[],"coverImages":[],"title":"医药板块速评（2023.11.17)","html":"<html><head></head><body><p style=\"text-align: start;\">1、生物医药板块接连突破， 哪些优质医药股还有配置机会？ <a href=\"https://laohu8.com/S/XBI\">$SPDR S&amp;P Biotech ETF(XBI)$</a> </p>\n<p style=\"text-align: start;\">2、减肥药大年，还有哪些GLP-1药企有机会？ <a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a> <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> </p>\n<p style=\"text-align: start;\">3、 <a href=\"https://laohu8.com/S/IMGN\">$ImmunoGen(IMGN)$</a> 大单看涨期权，是否有被收购机会？</p>\n<p> <a href=\"https://laohu8.com/S/ZLAB\">$再鼎医药(ZLAB)$</a> </p></body></html>","htmlText":"<html><head></head><body><p style=\"text-align: start;\">1、生物医药板块接连突破， 哪些优质医药股还有配置机会？ <a href=\"https://laohu8.com/S/XBI\">$SPDR S&amp;P Biotech ETF(XBI)$</a> </p>\n<p style=\"text-align: start;\">2、减肥药大年，还有哪些GLP-1药企有机会？ <a href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a> <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> </p>\n<p style=\"text-align: start;\">3、 <a href=\"https://laohu8.com/S/IMGN\">$ImmunoGen(IMGN)$</a> 大单看涨期权，是否有被收购机会？</p>\n<p> <a href=\"https://laohu8.com/S/ZLAB\">$再鼎医药(ZLAB)$</a> </p></body></html>","text":"1、生物医药板块接连突破， 哪些优质医药股还有配置机会？ $SPDR S&P Biotech ETF(XBI)$ 2、减肥药大年，还有哪些GLP-1药企有机会？ $礼来(LLY)$ $诺和诺德(NVO)$ 3、 $ImmunoGen(IMGN)$ 大单看涨期权，是否有被收购机会？ $再鼎医药(ZLAB)$","highlighted":1,"essential":1,"paper":2,"likeSize":1,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/243588194050112","repostId":0,"isVote":1,"tweetType":1,"viewCount":4304,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["IMGN","ZLAB","LLY","NVO","XBI","09688"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":202,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":247405149643048,"commentId":"247405149643048","gmtCreate":1701439514815,"gmtModify":1701439518784,"authorId":3452938437060827,"author":{"id":3452938437060827,"idStr":"3452938437060827","authorId":3452938437060827,"name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1,"categoryType":2007}]},"repliedAuthorId":0,"objectId":243588194050112,"objectIdStr":"243588194050112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"<a href=\"https://laohu8.com/S/IMGN\" target=\"_blank\">$ImmunoGen(IMGN)$ </a>提前布局。<br>","text":"<a href=\"https://laohu8.com/S/IMGN\" target=\"_blank\">$ImmunoGen(IMGN)$ </a>提前布局。<br>","html":"<a href=\"https://laohu8.com/S/IMGN\" target=\"_blank\">$ImmunoGen(IMGN)$ </a>提前布局。<br>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"hasMoreComment":true,"orderType":2}